文献速递抗栓抗凝管理药物不良反应与药物警戒

抗凝暴露错分对直接口服抗凝药出血风险的影响

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants.
PubMed 文献 · Br J Clin Pharmacol · 2021-03-04

基于荷兰PHARMO数据库2008–2017年新使用抗凝药者,比较仅用全科医生或专科医生处方数据与完整配药数据时,DOAC对比VKA的大出血及卒中/TIA风险估计变化;仅全科医生处方数据未实质影响效应估计,仅专科医生处方数据则强化效应估计。

要点

  • 仅用全科医生处方数据估计DOAC vs VKA大出血风险与完整数据结果相近。
  • 仅用专科医生处方数据会强化DOAC较低大出血风险的效应估计。
  • 暴露错分对卒中/TIA的效应估计影响与出血结局类似。

核心结论

  • 仅纳入全科医生处方抗凝配药信息未实质影响DOAC vs VKA的效应估计,而仅纳入专科医生处方信息则强化了效应估计。

主要发现

  • DOAC vs VKA大出血住院风险比:完整配药信息HR 0.79(95%CI 0.70-0.90),仅全科医生处方HR 0.78(0.68-0.91),仅专科医生处方HR 0.62(0.50-0.76)。
  • 其他出血结局结果类似。
  • 卒中/TIA风险比:完整配药信息HR 0.96(0.84-1.09),仅全科医生处方HR 1.00(0.84-1.18),仅专科医生处方HR 0.72(0.58-0.90)。

临床怎么用

  • 使用常规处方数据评估DOAC与VKA比较效果时,需注意仅纳入专科医生处方可能强化效应估计,应尽量使用完整配药信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Drug exposure status based on routinely collected data might be misclassified when the database contains only prescriptions from 1 type of prescriber (e.g. general practitioner and not specialist). This study aims to quantify the impact of such exposure misclassification on the risk of major bleeding and stroke/transient ischaemic attack (TIA)associated with direct oral anticoagulants (DOACs) vs. vitamin K antagonists (VKAs). METHODS: Incident anticoagulant users (>12 mo free of anticoagulation use) in the Dutch PHARMO Database Network between 2008 and 2017 were included. Drug exposure was assessed using pharmacy dispensing information. The risks of hospital admission of major bleeding for DOAC vs. VKA users was assessed with Cox regression analysis, where exposure was based on all dispensings, on general practitioner (GP)-prescribed dispensings only or on specialist-prescribed dispensings only. Hazard ratios (HRs) were estimated also for hospitalization for gastrointestinal bleeding, intracranial bleeding and stroke/TIA. RESULTS: We included 99 182 VKA-initiators and 21 795 DOAC-initiators. Use of DOAC was associated with a lower risk of major bleeding compared to VKA use; HR 0.79 (95% confidence interval 0.70-0.90), 0.78 (0.68-0.91) and 0.62 (0.50-0.76), for exposure based on complete dispensing information, only GP- and only specialist-prescribed dispensings, respectively. Similar results were found for the other bleeding outcomes. For stroke/TIA the HRs were 0.96 (0.84-1.09), 1.00 (0.84-1.18) and 0.72 (0.58-0.90), respectively. CONCLUSION: Including only GP-prescribed anticoagulant dispensings in this case did not materially impact the effect estimates compared to including all anticoagulant dispensings. Including only specialist-prescribed dispensings, however, strengthened the effect estimates.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Hempenius M, Groenwold RHH, Souverein PC, et al. Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants. Br J Clin Pharmacol. 2021. PMID: 33543516. doi:10.1111/bcp.14764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。